Related Experiment Videos
[Staging laparotomy in gynecologic cancer]
1Department of Gynecology and Obstetrics, Kyushu University Faculty of Medicine, Fukuoka.
Nihon Sanka Fujinka Gakkai Zasshi
|August 1, 1989
Summary
Surgical staging, including para-aortic lymph node biopsy and peritoneal cytology, is crucial for gynecologic cancers. Accurate staging impacts treatment individualization and patient prognosis.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Clinical Staging
Context:
- Clinical staging of gynecologic cancers often differs significantly from surgical findings (20-50%).
- Accurate disease extent determination is vital for effective treatment planning.
- Staging laparotomy provides essential histological information for personalized therapy.
Purpose:
- To evaluate the utility of staging laparotomy in determining the precise histological extent of gynecologic cancers.
- To assess the prognostic value of para-aortic lymph node (PAN) biopsy, scalene lymph node (SLN) biopsy, and peritoneal cytology.
- To individualize treatment strategies based on detailed disease spread patterns.
Summary:
- Para-aortic lymph node (PAN) biopsy in 419 cervical cancer patients revealed a 5.5% positivity rate, increasing with clinical stage (up to 25% in Stage IV).
- Scalene lymph node (SLN) biopsy was positive in 17.6% of cases with positive PAN, and all SLN-positive patients died within 2 years.
- Peritoneal cytology (11.2% positive) and pelvic lymphadenectomy in endometrial cancer (16.3% positive) also demonstrated significant prognostic value.
Impact:
- Staging laparotomy improves the accuracy of disease assessment, guiding individualized treatment for gynecologic malignancies.
- Para-aortic lymph node involvement and peritoneal cytology are critical prognostic indicators.
- Findings support the routine use of comprehensive surgical staging for optimal gynecologic cancer management.